PSTV

Plus Therapeutics, Inc. PSTV

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PSTV NXTC BOLD TAOX QTTB VRCA ANTX JSPR INTS ITRM
6M 189.59 % 88.30 % 20.19 % 31.13 % 98.43 % 43.25 % 3.64 % -62.70 % 46.21 % -60.63 %
YTD -52.39 % 7.71 % -54.21 % 31.13 % -10.85 % 19.20 % -17.99 % -90.89 % -76.86 % -78.70 %
1Y -43.25 % -6.84 % -50.40 % 31.13 % -7.91 % 23.96 % -10.24 % -91.08 % -79.75 % -77.73 %
3Y -87.92 % -31.40 % 12 499 900.00 % 31.13 % -86.86 % -69.53 % -88.37 % -66.54 % -93.20 % -60.94 %
5Y -98.25 % -91.49 % 12 499 900.00 % 31.13 % -98.67 % -92.14 % -92.60 % -98.10 % -93.20 % -97.34 %
10Y -100.00 % -95.55 % 12 499 900.00 % 31.13 % -99.08 % -95.21 % -92.60 % -98.04 % -93.20 % -99.80 %
From the beginning -100.00 % -95.55 % 12 499 900.00 % 31.13 % -99.08 % -95.21 % -92.60 % -98.04 % -93.20 % -99.80 %

Dividend

AN2 Therapeutics, Inc.